Tweetovi

Blokirali ste korisnika/cu @PetMedix

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PetMedix

  1. Prikvačeni tweet
    31. sij

    We’re absolutely delighted to be voted ‘Best Start-up 2019’ in the Awards! A reflection of the outstanding work put in by the PetMedix team to develop cutting edge therapeutics for companion animals.

    Poništi
  2. 3. velj

    The team at PetMedix are delighted to be awarded Best Startup 2019 in the Awards. Great !

    Poništi
  3. 31. sij

    It's reasonable to assume a similar treatment failure rate in animals. Our targeted therapies aim to provide a highly effective treatment option for our dogs and cats.

    Prikaži ovu nit
    Poništi
  4. 31. sij

    The percentage of human patients in which a diagnosis has been made, but for which standard drug treatment is ineffective ranges from 38% to 75%.

    Prikaži ovu nit
    Poništi
  5. 31. sij

    Proud to be judged 2019. Many thanks to the judging panel and congratulations to the other worthy winners.

    Poništi
  6. 28. sij

    PetMedix technology is at the cutting-edge of advanced treatment development. Watch our explainer video and read about our platform on our website to find out more

    Poništi
  7. 24. sij

    In time, precision medicine is likely to impact a wide variety of diseases, including diabetes, obesity, and various infectious disease that occur in both animals and people.

    Poništi
  8. 20. sij

    Our for making the best treatments available for pets. Treating the untreatable to give them longer, happier, healthier lives.

    Poništi
  9. 17. sij

    Precision medicine is transforming cancer treatment in human health. Molecular guided treatments have the potential to provide improved outcomes, compared with nontargeted interventions such as surgery, radiation, and chemotherapy alone.

    Poništi
  10. 14. sij

    We're excited to be developing the gold standard of monoclonal antibody therapies from human health to benefit our pets and yours.

    Poništi
  11. 13. sij

    Are you in this week and interested in how PetMedix are developing the next tier of medicines? Contact us to arrange a meeting.

    Poništi
  12. 10. sij

    PetMedix Founders Dr. Tom Weaver and Dr. Jolyon Martin will be in San Francisco 11th-16th January. Contact us to arrange a meeting and find out about our cutting-edge platform transforming .

    Poništi
  13. 9. sij

    Clinical trials involving human and animal patients with a variety of cancers are increasingly providing information about shared driver mutations that constitute important drug targets. Our technology has the potential for significant benefits.

    Poništi
  14. 6. sij

    We're hiring in 2020! Visit our careers page to find out how you can join our fantastic team developing the next generation of effective treatments for pets worldwide.

    Poništi
  15. 3. sij

    Precision medicine is a focus in and human . Rather than standard treatment for any given illness, sees patients receive one that is tailored to their condition. This improves the outcome as patients are targeted with the 'best fit' treatment.

    Poništi
  16. 1. sij

    WELCOME TO 2020! The decade where PetMedix will launch our monoclonal antibodies therapies to improve the health and welfare of pets and their owners. #2020

    Poništi
  17. 31. pro 2019.

    Thanks to all you who have followed PetMedix exciting progress through 2019 - wishing you a very HAPPY NEW YEAR and looking forward to seeing you in 2020!

    Poništi
  18. 27. pro 2019.

    A truly global 2019 saw PetMedix represented at FELASA conference in Prague, Health in the USA, in the UK, and Animal Health Innovation Asia in Tokyo.

    Poništi
  19. 24. pro 2019.

    Wishing all our followers, staff, supporters and - of course - their pets, a very happy and healthy festive season.

    Poništi
  20. 20. pro 2019.

    2020 will see us moving into new facilities at Insititue. We're excited to have secured such sought after space in the heart of the science cluster.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·